114 filings
Page 3 of 6
8-K
l3426ltek
16 Nov 22
Regulation FD Disclosure
9:05am
8-K
1ibmh n9al
14 Nov 22
Virios Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update
7:30am
8-K
hxzkfr3gv4
2 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
ybeteeblcc
27 Sep 22
Regulation FD Disclosure
8:00am
424B4
t024etwcygc xu
21 Sep 22
Prospectus supplement with pricing info
11:26am
8-K
mndtvoh
20 Sep 22
Virios Therapeutics, Inc. Announces Proposed Public Offering
8:14am
FWP
xtktvqva
19 Sep 22
Free writing prospectus
4:26pm
424B4
e2nkh3fe
19 Sep 22
Prospectus supplement with pricing info
4:25pm
8-K
qgl23ag
19 Sep 22
Virios Therapeutics Announces Top-Line Results from Phase 2b Study of IMC-1 in Fibromyalgia
7:30am
8-K
xbxsgzvv1fy
11 Aug 22
Virios Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
7:31am
S-8
eiko4w1gtglq5h
22 Jun 22
Registration of securities for employees
9:06am
8-K
q2gpqvr
17 Jun 22
Departure of Directors or Certain Officers
12:06pm
8-K
k83kl5
3 Jun 22
Changes in Registrant's Certifying Accountant
12:46pm
DEFA14A
82209lr
16 May 22
Additional proxy soliciting materials
3:00pm
8-K
rqk3msj
12 May 22
Virios Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update
7:30am
EFFECT
t9a6ix qn9vx3z34z5
29 Apr 22
Notice of effectiveness
12:15am